HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

SB 216763

a glycogen synthase kinase-3 inhibitor; structure in first source
Also Known As:
3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione; SB-216763
Networked: 9 relevant articles (2 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Sharma, Pyare Lal: 1 article (10/2012)
2. Yadav, Harlokesh Narayan: 1 article (10/2012)
3. Singh, Manjeet: 1 article (10/2012)
4. Hu, Dahai: 1 article (01/2012)
5. Liu, Jiaqi: 1 article (01/2012)
6. Han, Juntao: 1 article (01/2012)
7. Su, Yingjun: 1 article (01/2012)
8. Tang, Chaowu: 1 article (01/2012)
9. Pan, Qing: 1 article (01/2012)
10. Wang, Yunchuan: 1 article (01/2012)

Related Diseases

1. Ischemia
2. Carcinoma (Carcinomatosis)
3. Hypertrophic Cicatrix (Hypertrophic Scar)
4. Pneumonia (Pneumonitis)
5. Myocardial Infarction

Related Drugs and Biologics

1. Lithium
2. Therapeutic Uses
3. 2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- one
4. Glycogen Synthase Kinase 3
5. Morphine (MS Contin)
6. Glycogen Synthase (Synthase I)
7. Fentanyl (Sublimaze)
8. Collagen
9. glycogen synthase kinase 3 beta
10. 3- (3- chloro- 4- hydroxyphenylamino)- 4- (4- nitrophenyl)- 1H- pyrrole- 2,5- dione